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Research
2020, cardiovascular disease and depression
will be the two leading contributors to bur-
den of disease in terms of disability-adjusted
life years.1 Furtherm re, many people with
cardiovascular conditions have significant
co-existing depressive symptoms that may








Objective:  To evaluate the effect on depressive symptoms in cardiac patients of 
patient-specific advice to general practitioners regarding management of comorbid 
depression.
gn and setting:  A randomised controlled trial in four general hospitals in 
aide, South Australia.
cipants:  Patients (n = 669) admitted to cardiology units for a range of 
ovascular conditions who were screened and assessed as being depressed 
rding to the Center for Epidemiological Studies Depression Scale (CES-D).
vention:  Inpatient psychiatric review, followed by telephone case conferencing 
een specialist hospital staff and GPs to provide patient-specific information about 
the patient’s depression and its management, educational material, and ongoing clinical 
support.
Main outcome measures:  Level of depression severity at 12 months post-
hospitalisation.
Results:  On the basis of intention to treat, intervention patients had lower rates of
moderate to severe depression (CES-D  27) after 12 months (25% v 35%, relative risk,
0.72; 95% CI, 0.54–0.96, number needed to treat for benefit, 11). The intervention was
most effective in preventing progression from mild depression to moderate to severe
depression. The multidisciplinary telephone case conferencing was difficult to imple-
ment and, in a post hoc analysis, brief phone advice from a psychiatrist was found to be
effective.
Conclusions:  Screening hospitalised cardiac patients for depression and providing 
MJA 2005; 182: 272–276
targeted advice to their GPs reduces depression severity 12 months after hospitalisation.ard
bo
sidC iovascular disease and depressionth have high prevalence and con-erable impacts in terms of mortal-
ity and morbidity. The World Health
Organization (WHO) estimates that, by
adverse outcomes in coronary heart disease
increases in proportion to severity of depres-
sion — up to two-fold increased risk has
been reported for minor depression, and
major depression carries up to five times
increased risk.5,6
Disappointing findings7 have emerged
recently from two randomised controlled
trials, one examining the effect of sertraline
(SADHART)8 and the other psychotherapy
(ENRICHD),9 on reduction of depressive
symptoms in post-myocardial infarction
patients with major depression. Explana-
tions for the modest reductions in depres-
sive symptoms in these studies have stressed
difficulties with delivering complex psycho-
social interventions such as cognitive behav-
iour therapy9 to patients with severe
physical illness.
Given that only a minority of patients
with cardiovascular disease who are
depressed are treated for depression,10 we
were interested in discovering whether iden-
tifying comorbid depression and delivering
a pragmatic primary-care-focused interven-
tion could reduce depression severity in
recently hospitalised cardiac patients. We
reasoned that a simple intervention deliv-
ered by general practitioners, if effective,
might have significant public health conse-
quences. Our approach was consistent with
findings that providing depression scale
scores to GPs improves the recognition of
depression,11 and that treatment of depres-
sion in primary care can be improved by
specific patient-focused consultations
between GPs and psychiatrists providing
management advice and feedback.10,12,13
Provision of depression screening results
alone is not sufficient to improve out-
comes,11 and as yet no intervention has
been reported to be both effective in reduc-
ing comorbid depression in cardiac patients
and easy to deliver in a primary care setting.
The Identifying Depression as a Comor-
bid Condition (IDACC)14 randomised con-
trolled trial used the Enhanced Primary Care
(EPC) program introduced by the Australian
government to reimburse GPs for participat-
ing in multidisciplinary case conferencing.
The primary outcome measure was the level
of depression at 12 months post-hospitalisa-
tion. Here, we report the results, on the




Our randomised controlled trial examined
the effect on depressive symptoms of pro-
viding patient-specific psychiatric telephone
advice to the GPs of patients who had beenMJA • Volume 182 Number 6 • 21 March 2005
RESEARCHhospitalised for a range of cardiac condi-
tions, and who had been identified during
hospitalisation as depressed. This interven-
tion was compared with usual care.
The trial was part of the prospective
IDACC study,14,15 which monitored depres-
sion, quality of life and service utilisation in
a cohort of recently discharged cardiac
patients. The trial was conducted in four
major public hospitals in Adelaide over 16
months from 1 August 2000 to 31 Decem-
ber 2001, with a 6-month extension in one
hospital. Inclusion of this latter group
updates study details previously reported.14
Study population
Patients aged between 18 and 84 years and
admitted to cardiology units for myocardial
infarction, unstable angina, arrhythmia,
congestive heart failure, coronary artery
bypass graft surgery or angioplasty were
eligible for inclusion. Of 3358 patients
assessed for eligibility, 1245 were excluded
(Box 1). Of the 2113 assessed as eligible and
approached, 538 refused to participate,
resulting in a cohort of 1541, which repre-
sents a 73% consent rate (Box 1).
A comparison of consenters and non-
consenters showed that non-consent was
associated with being older (P < 0.001) and
female (P < 0.001). There was no significant
difference in consent rates by reason for
admission. Project assistants usually
approached patients on Day 2 or 3 of admis-
sion, and eligible consenting patients were
screened for depressive symptoms using the
Center for Epidemiological Studies Depres-
sion Scale (CES-D).16 The CES-D has been
widely used in cardiac17,18 and older popu-
lations.19 It has good face validity,20 is quick
and easy to administer and score, and has
been recommended as suitable for use as a
screening instrument for primary care
patients.19,21 Rates of depression reported
using the CES-D are similar to those of
coronary patients assessed by other self-
report scales or clinical interview.2 Consist-
ent with previous research, cut-off scores of
CES-D  16 were used to determine depres-
sion “caseness” in this analysis, and
depressed patients were further differenti-
ated as having mild depression (CES-D 16–
26), or moderate to severe depression (CES-
D  27).18-20,22-25 The SF-3626 was adminis-
tered as a self-report measure of physical
and mental health-related quality of life.
At 12 months post-hospitalisation, all
patients were sent follow-up postal ques-
tionnaires. A follow-up rate of 78.4% was
achieved in those not withdrawn or
deceased at this time, with no significant
difference between control and intervention
groups.
Randomisation
Patients fulfilling criteria for depression
caseness at baseline were centrally ran-
domised into the trial on the basis of the GP
caring for them. Patients randomised into
the control arm of the trial received usual
cardiac and non-cardiac care, both in the
hospital and in the community. In all, 480
GPs were nominated by the 669 patients.
Most GPs (75%) had only one patient par-
ticipating in the IDACC study, with no
significant difference between the interven-
tion and control groups in the proportion of
GPs with more than one trial patient.
Intervention
Intervention patients were referred to the
psychiatric consultation liaison service for
an in-hospital psychiatric consultation, and
the cardiac rehabilitation nurse was notified.
Patients were seen independently by the
rehabilitation nurse and psychiatry liaison
registrar, who received an initial training
session from the chief investigators and
ongoing supervision from the senior hospi-
tal consultation liaison psychiatrist.
Consultations followed routine practice,
although the psychiatry registrar was
required to complete a checklist15 of any
issues identified, which could be subse-
quently used as a basis for discussion with
the GP. Consultations on average lasted 20–
30 minutes.
The patient’s depression screening scores
and a copy of an evidence-based treatment
guide developed for IDACC were sent to the
patient’s GP.15 The treatment guide incorpo-
rated information about recognition of
depression and treatment options (medica-
tion and cognitive behavioural therapy). The
GP was invited to take part in a 15–30
minute telephone case conference with the
attending psychiatric registrar and cardiac
rehabilitation nurse.
1 Flow of participants through the trial
Cardiac inpatients,
assessed for eligibility (n = 3358)
Eligible
(n = 2113, 62.9%)
Ineligible
(n = 1245, 37.1%)
Reasons for exclusion: 
Language (n = 433, 34.8%)
Severe cognitive or physical  
   impairment (n = 503, 40.4%)
Other trials (n = 259, 20.8%)
Other (n = 50, 4.0%)
Approached
Consented
(n = 1541, 72.9%)
Consented but did not
participate (n = 34, 1.6%)
Refused
(n = 538, 25.5%)
Screened for depressive symptoms, CESD-D >16
Depressed
(n = 669, 43.4%)
Not depressed
(n = 872, 56.6%)
Randomised
Intervention
(n = 331, 49.5%)
Follow-up at 12 months
Returned questionnaire
(n = 213 / 274, 77.7%)
Died (n = 22, 6.6%)
Withdrew (n = 35, 10.6%)
Follow-up at 12 months
Returned questionnaire
 (n = 237 / 298, 79.5%) 
Died (n = 19, 5.6%)
Withdrew (n = 21, 6.2%)
GP education with screening results,
case conference/ telephone advice
Control
(n = 338, 50.5%)MJA • Volume 182 Number 6 • 21 March 2005 273
RESEARCHWhenever the psychiatric registrar was
unable to review the patient before dis-
charge, or it was not logistically possible to
organise a formal case conference, an alter-
native intervention was implemented. In
lieu of the case conference, GPs were
offered a one-to-one standardised 5–10
minute phone consultation with a desig-
nated psychiatrist (G S) who had not seen
the patient. This telephone call centred on
the GP’s knowledge of the patient, the
patient’s depression scores, the IDACC
guidelines for management of heart disease
and depression in general practice, and
suggestions for management. A critical
component of either intervention was the
opportunity for the GP to discuss, by tele-
phone, the psychological state of their
patient with a psychiatrist or psychiatric
registrar, who provided management
advice tailored to the specific patient.
Where neither form of telephone consul-
tation could be delivered, the GP received,
by post, the patient’s depression rating
scores and a copy of the management guide-
lines.
Sample size
To detect a 15% difference between the inter-
vention and control groups with a spontane-
ous resolution of 50% of depressed cases27
(χ2 two-sided test with alpha of 0.05, and
80% power), we calculated that the sample
size required was 183 in each arm, with level
of moderate to severe depressive symptoms at
12 months after hospitalisation as a primary
outcome measure.
Statistical analysis
Results were analysed on an intention-to-
treat basis, with moderate to severe depres-
sion at 12 months as the primary outcome,
using SPSS for Windows.28 Mixed model
analysis in SPSS was initially conducted to
account for randomisation clustered by GP.
The decision to analyse CES-D categories
rather than CES-D scale scores was taken for
three reasons:
• the CES-D categories of not depressed,
mild depression and moderate to severe
depression may be more meaningful to cli-
nicians;
• evidence shows risk of adverse outcome
is associated with both mild and moderate
to severe CES-D categories;17 and
• CES-D scores were not normally distrib-
uted.
We analysed outcomes at 12 months
using χ2 tests, and results are presented as
relative risks (RR) with 95% confidence
intervals. To determine clinical significance,
we report the number needed to treat
(NNT) to produce benefit in one patient,
calculated as the inverse of the absolute risk
difference. Unpaired t test comparisons of
intervention versus control SF-36 scores
were conducted. Post hoc χ2 analysis was
conducted between the outcomes of the
control group and levels of the intervention
actually delivered, with significance level
adjusted using the Bonferroni method.
Funding and ethical approval
The IDACC project was funded by the
South Australian Department of Health,
partly through grants provided by the Aus-
tralian National Mental Health Strategy.
Ethical approval was obtained from the
respective local hospital Human Research
Ethics Committees.
RESULTS
Overall, 669 (43.4%) participants were
classified as depressed according to our
criterion of CES-D 16 and were ran-
domised to the trial (intervention, 331;
usual care, 338 ). Although patients were
randomised on the basis of the GP caring
for them, only 52 of the 248 intervention
group GPs and 67 of the 232 control group
GPs had more than one patient in the
study. Clustering by GP was not accounted
for in the analyses as no intra-class correla-
tion was detected in a mixed model analy-
sis, and the covariance parameter (GP) was
found to be redundant.
At baseline, 44% of the intervention
group were classified as having moderate to
severe depression (CES-D mean score,
35.5; standard deviation [SD], 7.0) and
56% as having mild depression (CES-D,
20.3; SD, 3.0). Forty-six per cent of the
control group were classified as having
moderate to severe depression (CES-D,
34.7; SD, 6.4) at baseline, with 54% in the
mild depression category (CES-D, 20.5;
SD, 3.2). Sixty-two per cent of study par-
ticipants were males. About 52% of
patients were admitted with unstable
angina and 20% with myocardial infarc-
tion. More than 65% of patients stated that
they had a past history of heart disease and
37% had a history of depression, anxiety or
stress. At baseline, there was no difference
between the intervention and control
groups on any variable.
At 12 months, 41 patients had died, with
no significant difference in numbers in the
intervention arm or the control arm, or the
baseline depression level within these
groups. A further 56 subjects had with-
drawn by 12 months (intervention, 35; con-
trol, 21), with no difference in their baseline
depression level. Of the remaining 572
patients, 450 (78.4%) returned question-
naires at 12 months. Overall, patients who
did not return the 12-month questionnaire
were more likely to be younger (P < 0.001);
divorced or separated (P < 0.001); or current
smokers (P < 0.001); but did not differ on
their baseline level of depression.
Comparing CES-D depression categories
between the intervention and control arms
showed a significant intervention effect at 12
months post-hospitalisation (Box 2).
Adjusted standardised residuals revealed
that patients in the intervention group were
less likely to have moderate to severe
depression at 12 months, compared with
controls (RR, 0.72; 95% CI, 0.54–0.96;
NNT, 11; 95% CI, 6–81).
Further analyses found that the interven-
tion resulted in a significant reduction in the
proportion of moderately to severely
depressed patients only in those who had
mild depression at baseline (χ2 = 5.043; df =
1; n = 450; P = 0.025) (Box 3).
To assess whether differences in depres-
sion severity at 12 months were related to
differences in physical health status, we
2 Depression severity measured by CES-D category
Not depressed Mild Moderate to severe
Baseline*
Intervention — 187 (57%) 144 (44%)
Control — 184 (54%) 154 (46%)
12 months†
Intervention 86 (40%) 74 (35%) 53 (25%)
Control 93 (39%) 62 (26%) 82 (35%)
— Patients who were not depressed at baseline did not participate in this trial. * χ2 = 0.29, df = 1, n = 669, 
P = 0.59. † χ2 = 6.30, df = 2, n = 450, P = 0.043.274 MJA • Volume 182 Number 6 • 21 March 2005
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at baseline and 12 months. There was no
significant difference between the control
and intervention groups in self-reported
physical health (physical health summary
scores were 34.3 and 33.1, respectively, at
baseline, 37.6 and 36.7 at 12 months).
Overall, in 24% of intervention patients
the full intervention with an EPC case con-
ference was delivered. “Telephone advice”
was provided for 39.9% and the “GP educa-
tion only” intervention was provided in 36%
of cases. Although not randomly allocated,
no difference was found between baseline
characteristics of patients in the control
group and the three forms of the interven-
tion delivered. When the three forms of the
intervention were compared (post hoc) with
the control group, only the psychiatrist tele-
phone call led to a significant reduction in
the proportion of patients with moderate to
severe depression (CES-D  27, 19% v
35%; RR, 0.55; 95% CI, 0.33–0.86).
DISCUSSION
Given the high prevalence of depression in
patients with cardiovascular disease and the
increasing recognition of the negative effect
of depression on outcome, simple and effec-
tive strategies for treating cardiac patients
with depression are required. This trial has
demonstrated a clinically meaningful reduc-
tion in depression severity in cardiac
patients 12 months after hospitalisation.
Importantly, the effect was most evident in
reducing the proportion of patients with
moderate to severe depression, the form of
depression most likely to lead to adverse
health outcomes. Our results suggest that
the intervention prevented mild depression
from developing into moderate to severe
depression. The lower proportion of
patients with moderate to severe depression
in the intervention group was unlikely to be
related to any differences in physical health
as there were no differences in the SF-36
physical subscale between the groups at
either baseline or 12 months. It is notewor-
thy that the substantial reduction of depres-
sion severity was achieved with a relatively
simple GP-mediated intervention. As such,
the intervention may be more easily and
cheaply implemented than the more com-
plex therapy-based interventions tested in
the ENRICHD study.9
The intervention had little effect on the
proportion of patients classified as not
depressed at 12 months. Further, the inter-
vention did not appear to be effective in
reducing depression severity in patients
who had moderate to severe depression at
baseline. It may be that this group of
patients require more intensive support than
that provided by the IDACC GP-focused
intervention. Of note, a multivariate analysis
of the overall prospective IDACC cohort
demonstrated that severity of baseline
depressive symptoms was a powerful pre-
dictor of persistent depression in cardiac
patients.29
Even with substantial infrastructure sup-
porting the project, in-patient visits by psy-
chiatry liaison and the cardiac rehabilitation
nurse, followed by multidisciplinary EPC
case conferences, were logistically complex
and difficult to implement. Interestingly,
post hoc analysis indicated that EPC case
conferencing may not be the most effective
way to liaise with GPs. The alternative inter-
vention involving a telephone call from a
psychiatrist to the GP was not only easier to
implement, particularly within the general
hospital, but also effective in reducing
depression severity in the GP’s patients com-
pared with the control group. This finding
requires further prospective evaluation.
There were several limitations to our
study. Although overall consent rates were
high, the patients not returning question-
naires at 12 months were more likely to be
younger, divorced or separated, and smok-
ers. We do not know what management
plans for depression were actually delivered
by individual GPs. Further analysis of the
data, including analysis of comparative rates
of antidepressant prescription and service
utilisation data (collected during the IDACC
project), may elucidate which aspects of the
intervention were most important in reduc-
ing depression severity.
We consider our findings are important
and have implications for improving care for
cardiac patients with comorbid depression.
Both depression and cardiovascular disease
have high prevalence, and depression
remains underdiagnosed and undertreated
in this population. Our findings may pro-
vide a different approach to the practice of
consultation liaison psychiatry in the con-
temporary general hospital, where care is
increasingly orientated to brief stays for
investigations and procedures. Such an
approach would involve screening of
patients known to be at high risk of psycho-
logical distress (eg, cardiac in-patients), and
subsequently providing targeted support to
the GPs for patients identified as being at
risk of adverse outcomes.
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